340 related articles for article (PubMed ID: 30689267)
1. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
Lu Q; Lu D; Shao ZM; Li DQ
Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
[TBL] [Abstract][Full Text] [Related]
2. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation.
Xie Y; Avello M; Schirle M; McWhinnie E; Feng Y; Bric-Furlong E; Wilson C; Nathans R; Zhang J; Kirschner MW; Huang SM; Cong F
J Biol Chem; 2013 Feb; 288(5):2976-85. PubMed ID: 23184937
[TBL] [Abstract][Full Text] [Related]
4. RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.
Wang Z; Nie Z; Chen W; Zhou Z; Kong Q; Seth AK; Liu R; Chen C
Neoplasia; 2013 Sep; 15(9):1028-35. PubMed ID: 24027428
[TBL] [Abstract][Full Text] [Related]
5. USP9X destabilizes pVHL and promotes cell proliferation.
Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y
Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496
[TBL] [Abstract][Full Text] [Related]
6. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
7. Multifaceted Roles of the E3 Ubiquitin Ligase RING Finger Protein 115 in Immunity and Diseases.
Wang MX; Liuyu T; Zhang ZD
Front Immunol; 2022; 13():936579. PubMed ID: 35844553
[TBL] [Abstract][Full Text] [Related]
8. USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle.
Song N; Deng L; Zeng L; He L; Liu C; Liu L; Fu R
Mol Carcinog; 2023 Oct; 62(10):1487-1503. PubMed ID: 37314216
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1.
Trivigno D; Essmann F; Huber SM; Rudner J
Neoplasia; 2012 Oct; 14(10):893-904. PubMed ID: 23097624
[TBL] [Abstract][Full Text] [Related]
10. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
[TBL] [Abstract][Full Text] [Related]
11. Targeting USP9x/SOX2 axis contributes to the anti-osteosarcoma effect of neogambogic acid.
Chen X; Zhang X; Cai H; Yang W; Lei H; Xu H; Wang W; Zhu Q; Kang J; Yin T; Gu W; Wu YL
Cancer Lett; 2020 Jan; 469():277-286. PubMed ID: 31605775
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
Li H; Zheng B
Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
[TBL] [Abstract][Full Text] [Related]
13. Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma.
Cox JL; Wilder PJ; Wuebben EL; Ouellette MM; Hollingsworth MA; Rizzino A
Cancer Biol Ther; 2014 Aug; 15(8):1042-52. PubMed ID: 24841553
[TBL] [Abstract][Full Text] [Related]
14. USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase.
Chen Y; Feng X; Wu Z; Yang Y; Rao X; Meng R; Zhang S; Dong X; Xu S; Wu G; Jie X
J Biomed Sci; 2024 May; 31(1):55. PubMed ID: 38802791
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
[TBL] [Abstract][Full Text] [Related]
16. USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification.
Nielsen CP; Jernigan KK; Diggins NL; Webb DJ; MacGurn JA
Cell Rep; 2019 Jul; 28(4):1074-1089.e5. PubMed ID: 31340145
[TBL] [Abstract][Full Text] [Related]
17. Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics.
Zhang J; Wang J; Luan T; Zuo Y; Chen J; Zhang H; Ye Z; Wang H; Hai B
Oncol Rep; 2019 Jun; 41(6):3292-3304. PubMed ID: 31002345
[TBL] [Abstract][Full Text] [Related]
18. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
[TBL] [Abstract][Full Text] [Related]
20. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM
Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
